BTQ Technologies Appoints Dr. Ro Cammarota to Accelerate QCIM Product Development, Commercialization, and Global Partnerships
-
has appointed Dr.BTQ Technologies Ro Cammarota to itsU.S. team to help accelerate the development, commercialization, and strategic partnerships for QCIM, the Company's post-quantum semiconductor platform.
-
Dr. Cammarota brings more than 20 years of experience in cryptography, privacy, and advanced chip design, including senior roles atIntel Labs , Qualcomm and theU.S. Department of Defense , where he led major research programs and hardware security initiatives.
- His appointment will strengthen BTQ's QCIM roadmap across core IP, certification, industry partnerships, and go-to-market execution as the Company advances its post-quantum hardware platform toward broader commercial deployment.
Prior to joining BTQ,
Prior to Intel,
"Ro is one of the leading minds in cryptographic hardware and advanced semiconductor security," said
"BTQ is uniquely positioned at the intersection of post-quantum security and advanced semiconductor design, addressing what we believe will become a foundational requirement for next-generation systems and defining the future of secure computing. QCIM represents a differentiated, high-performance approach to accelerating cryptographic workloads, and I look forward to helping advance its development and drive broad commercial adoption. Drawing on my experience leading large-scale cryptographic hardware programs and global standardization efforts, I'm excited to help accelerate QCIM from innovation to real-world deployment."
About BTQ
Connect with BTQ: Website | LinkedIn | X/Twitter
ON BEHALF OF THE BOARD OF DIRECTORS
CEO, Chairman
Neither Cboe Canada nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.
Forward Looking Information
Certain statements herein contain forward-looking statements and forward-looking information within the meaning of applicable securities laws. Such forward-looking statements or information include but are not limited to statements or information with respect to the business plans of the Company, including with respect to its research partnerships, and anticipated markets in which the Company may be listing its common shares. Forward-looking statements or information often can be identified by the use of words such as "anticipate", "intend", "expect", "plan" or "may" and the variations of these words are intended to identify forward-looking statements and information.
The Company has made numerous assumptions including among other things, assumptions about general business and economic conditions, the development of post-quantum algorithms and quantum vulnerabilities, and the quantum computing industry generally. The foregoing list of assumptions is not exhaustive.
Although management of the Company believes that the assumptions made and the expectations represented by such statements or information are reasonable, there can be no assurance that forward-looking statements or information herein will prove to be accurate. Forward-looking statements and information are based on assumptions and involve known and unknown risks which may cause actual results to be materially different from any future results, expressed or implied, by such forward-looking statements or information. These factors include risks relating to: the availability of financing for the Company; business and economic conditions in the post-quantum and encryption computing industries generally; the speculative nature of the Company's research and development programs; the supply and demand for labour and technological post-quantum and encryption technology; unanticipated events related to regulatory and licensing matters and environmental matters; changes in general economic conditions or conditions in the financial markets; changes in laws (including regulations respecting blockchains); risks related to the direct and indirect impact of COVID-19 including, but not limited to, its impact on general economic conditions, the ability to obtain financing as required, and causing potential delays to research and development activities; and other risk factors as detailed from time to time. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.
View original content to download multimedia:https://www.prnewswire.com/news-releases/btq-technologies-appoints-dr-ro-cammarota-to-accelerate-qcim-product-development-commercialization-and-global-partnerships-302729727.html
SOURCE
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/March2026/31/c4517.html